This strategy aligns with clinical guidelines suggesting that weight loss medications should be treated like chronic therapiessimilar to blood pressure or diabetes management
On one hand, IBD can lead to dysregulation of adipokines, shifting the balance towards a pro-inflammatory state, on the other hand obesity and higher BMI are associated with higher risk of developing IBD and worse clinical outcomes, particularly for UC
L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction [PMID: 16179521] Laboratory literature summary: L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction
Framing nutrition and activity as tools that enhance GLP-1 effectiveness makes advice feel relevant rather than repetitive
This can make stools harder and drier, leading to constipation
Across trials and real-world reports, up to 83 % of users experience at least one GI side-effect and many stop therapy early